Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2018 | Glioma biomarker research

Waiting for pathology results to determine the grade of glioma tissue prior to surgery requires time, which can be improved with the use of real-time visible markers. Kathreena Kurian, MBBS, MD, FRCPath (Neuro), from the University of Bristol, Bristol, UK, thinks that the combination of histopathological and intraoperative biomarkers could be the way forward, as she explains here. This interview was recorded at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.